OTCMKTS:LVTTF Levitee Labs (LVTTF) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free LVTTF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume20,055 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Levitee Labs alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Levitee Labs Stock (OTCMKTS:LVTTF)Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… LVTTF Stock News HeadlinesFebruary 16, 2024 | ca.finance.yahoo.comCresco Labs Inc. (CL.CN)August 9, 2023 | forbes.comVannevar LabsMarch 29, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.June 6, 2023 | news.microsoft.comHow Microsoft computer scientists and researchers are working to ‘solve‘ cancerMay 27, 2023 | finance.yahoo.comLVTTF - Levitee Labs Inc.April 21, 2023 | bbc.co.ukGame - Atomic LabsFebruary 6, 2023 | finance.yahoo.comIIROC Trading Halt - LVTApril 30, 2022 | ca.finance.yahoo.comLevitee Labs Inc. (LVTTF)March 29, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 1, 2022 | seekingalpha.comLevitee Labs appoints CEO; raises $1.5M via private offering of unitsFebruary 1, 2022 | finance.yahoo.comLevitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 MillionJanuary 18, 2022 | seekingalpha.comLevitee Labs to raise C$3M via private placementJanuary 12, 2022 | finance.yahoo.comLevitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE NutraceuticalsJanuary 10, 2022 | msn.comLevitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To OpioidsJanuary 10, 2022 | finance.yahoo.comLevitee Labs Partners with Canntab Therapeutics to Provide Alternatives to OpioidsJanuary 10, 2022 | finance.yahoo.comLevitee Labs Partners with Canntab Therapeutics to Provide Alternatives to OpioidsJanuary 6, 2022 | finance.yahoo.comCORRECTION - Levitee Labs Announces Medical Advisory BoardDecember 20, 2021 | finance.yahoo.comLevitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, CanadaNovember 25, 2021 | finance.yahoo.comStocks2Watch's Virtual Investor Luncheon Agenda Updated for Tuesday November 30November 15, 2021 | finance.yahoo.comLevitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta RegionNovember 10, 2021 | finance.yahoo.comLevitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British ColumbiaNovember 8, 2021 | finance.yahoo.comLevitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021November 8, 2021 | finance.yahoo.comLevitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded ProductsNovember 5, 2021 | finance.yahoo.comLevitee Labs Announces Gold Sponsorship of Wonderland Psychedelic Conference in MiamiOctober 21, 2021 | finance.yahoo.comLevitee Labs Enters into Credit Facility For Up To $12 MillionOctober 21, 2021 | finance.yahoo.comLevitee Labs Enters into Credit Facility For Up To $12 MillionOctober 18, 2021 | finance.yahoo.comLevitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health ConditionsSee More Headlines Receive LVTTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Levitee Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:LVTTF CUSIPN/A CIKN/A Webwww.leviteelabs.com Phone250-465-8640FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. David BentilCEO & DirectorMr. Marc MomeniExec. VP & Co-FounderMr. Pouya FarmandCo-FounderMr. Mackenzie Osborne C.F.A.Head of M&A, Co-Founder and DirectorMaigul Wickham CPAChief Financial OfficerDr. Fady Hannah-Shmouni FRCPCM.D., Chief Medical & Scientific Officer and Pres of ClinicsOlivia Belcher-CowardMarketing & Communications Mang.Mr. Azim Qazi M.B.A.Head of Ecommerce & Consumer Packaged GoodsMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors LVTTF Stock Analysis - Frequently Asked Questions How do I buy shares of Levitee Labs? Shares of LVTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LVTTF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Levitee Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.